Priscilla Hung
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Ethos Technologies to Report Q3 2026 Results on Nov 2. Ethos Technologies (LIFE) will release its third quarter 2026 financial results on November 2. The company has been given a market outperform rating and a new price target of $40 by Citizens. Whale traders were active in the stock during today’s session. The stock sits near a support level of $18.62 and shows a breakout signal on the Bollinger Bands.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Waystar Holding Shows Technical Breakout Setup. ChartMill reports that Waystar Holding has formed a high-quality technical breakout setup. This observation aligns with the stock's current RSI of 62.6, suggesting momentum is present. The company trades at a trailing P/E of 37.7, with an average analyst target of $33.77.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
XRX Faces Pressure from Rising Junk Bond Yields Amid Growth Plans. XRX is in a pressure zone as junk bond yields climb above 15%. The stock has risen 11.5% over the past three months, showing resilience. At the PRINTING United Expo 2026, Xerox announced a major expansion of its production print portfolio, signaling growth plans.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Guidewire Shares Rise as West Bend Expands AI Claims Platform. Guidewire Software shares climbed alongside other software peers, supported by news that West Bend is building an AI-driven claims foundation on the company's platform. This development highlights ongoing adoption of Guidewire's technology in insurance operations. The stock remains well below its 52-week high, with analysts maintaining a higher average price target.
Transaction History
| VEEV | ▼ Sell | Open Market | 750 | $196K | 9/9/2026 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 477 | $0 | 9/1/2026 | View on chart |
| LIFE | ▲ Buy | Grant | 7,022 | $0 | 8/8/2026 | View on chart |
| WAY | ▲ Buy | Grant | 9,303 | $0 | 6/3/2026 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 262 | $0 | 6/1/2026 | View on chart |
| XRX | ▲ Buy | Grant | 87,209 | $0 | 5/20/2026 | View on chart |
| VEEV | ▼ Sell | Open Market | 750 | $117K | 4/30/2026 | View on chart |
| VEEV | ▼ Sell | Open Market | 750 | $115K | 4/10/2026 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 262 | $0 | 3/1/2026 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 263 | $0 | 12/1/2025 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 262 | $0 | 9/1/2025 | View on chart |
| VEEV | ▼ Sell | Open Market | 171 | $49K | 7/7/2025 | View on chart |
| VEEV | ▼ Sell | Open Market | 172 | $49K | 7/3/2025 | View on chart |
| WAY | ▲ Buy | Grant | 5,134 | $0 | 6/16/2025 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 343 | $0 | 6/1/2025 | View on chart |
| XRX | ▲ Buy | Grant | 44,378 | $0 | 5/21/2025 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 342 | $0 | 3/1/2025 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 343 | $0 | 12/1/2024 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 343 | $0 | 9/1/2024 | View on chart |
| WAY | ▲ Buy | Grant | 8,695 | $0 | 6/10/2024 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 302 | $0 | 6/1/2024 | View on chart |
| XRX | ▲ Buy | Grant | 16,152 | $0 | 5/22/2024 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 302 | $0 | 3/1/2024 | View on chart |
| GWRE | ▼ Sell | Open Market | 1,545 | $161K | 12/20/2023 | View on chart |
| GWRE | ▼ Sell | Open Market | 475 | $50K | 12/20/2023 | View on chart |
| GWRE | ▼ Sell | Open Market | 1,812 | $188K | 12/19/2023 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 303 | $0 | 12/1/2023 | View on chart |
| GWRE | ▼ Sell | Open Market | 6,310 | $631K | 11/29/2023 | View on chart |
| GWRE | ▼ Sell | Open Market | 8,124 | $748K | 9/20/2023 | View on chart |
| GWRE | ▼ Sell | Open Market | 1,119 | $104K | 9/20/2023 | View on chart |
| GWRE | ▼ Sell | Open Market | 11,540 | $1.1M | 9/19/2023 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 3,821 | $0 | 9/15/2023 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 4,671 | $0 | 9/15/2023 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 342 | $0 | 9/15/2023 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 10,581 | $0 | 9/15/2023 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 302 | $0 | 9/1/2023 | View on chart |
| GWRE | ▼ Sell | Open Market | 2,513 | $176K | 6/21/2023 | View on chart |
| GWRE | ▼ Sell | Open Market | 1,981 | $141K | 6/20/2023 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 342 | $0 | 6/15/2023 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 326 | $0 | 6/1/2023 | View on chart |
| GWRE | ▼ Sell | Open Market | 2,523 | $194K | 3/20/2023 | View on chart |
| GWRE | ▼ Sell | Open Market | 1,941 | $150K | 3/17/2023 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 342 | $0 | 3/15/2023 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 327 | $0 | 3/1/2023 | View on chart |
| GWRE | ▼ Sell | Open Market | 9,547 | $668K | 1/18/2023 | View on chart |
| GWRE | ▼ Sell | Open Market | 2,979 | $183K | 12/19/2022 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 341 | $0 | 12/15/2022 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 326 | $0 | 12/1/2022 | View on chart |
| GWRE | ▼ Sell | Open Market | 7,402 | $465K | 9/19/2022 | View on chart |
| GWRE | ▲ Buy | Grant | 27,534 | $0 | 9/15/2022 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 380 | $0 | 9/15/2022 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 342 | $0 | 9/15/2022 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 3,869 | $0 | 9/15/2022 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 2,608 | $0 | 9/15/2022 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 3,821 | $0 | 9/15/2022 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 327 | $0 | 9/1/2022 | View on chart |
| GWRE | ▼ Sell | Open Market | 1,718 | $124K | 6/17/2022 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 379 | $0 | 6/15/2022 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 342 | $0 | 6/15/2022 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 254 | $0 | 6/1/2022 | View on chart |
| GWRE | ▼ Sell | Open Market | 1,985 | $180K | 3/18/2022 | View on chart |
| GWRE | ▼ Sell | Open Market | 1,166 | $107K | 3/18/2022 | View on chart |
| GWRE | ▼ Sell | Open Market | 1,679 | $148K | 3/17/2022 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 781 | $0 | 3/15/2022 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 938 | $0 | 3/15/2022 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 380 | $0 | 3/15/2022 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 342 | $0 | 3/15/2022 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 563 | $0 | 3/15/2022 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 651 | $0 | 3/15/2022 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 169 | $0 | 3/1/2022 | View on chart |
| GWRE | ▼ Sell | Open Market | 594 | $62K | 1/10/2022 | View on chart |
| GWRE | ▼ Sell | Open Market | 1,846 | $202K | 12/20/2021 | View on chart |
| GWRE | ▼ Sell | Open Market | 2,386 | $270K | 12/17/2021 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 379 | $0 | 12/15/2021 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 342 | $0 | 12/15/2021 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 562 | $0 | 12/15/2021 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 651 | $0 | 12/15/2021 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 781 | $0 | 12/15/2021 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 937 | $0 | 12/15/2021 | View on chart |
| GWRE | ▼ Sell | Open Market | 2,473 | $289K | 9/20/2021 | View on chart |
| GWRE | ▼ Sell | Open Market | 2,378 | $275K | 9/20/2021 | View on chart |
| GWRE | ▼ Sell | Open Market | 4,900 | $581K | 9/17/2021 | View on chart |
| GWRE | ▲ Buy | Option Exercise | 9,751 | $0 | 9/15/2021 | View on chart |
| GWRE | ▲ Buy | Grant | 18,794 | $0 | 9/14/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Veeva Gains Investor Attention Amid R&D Growth and AI Focus
Veeva Systems is drawing investor interest as analysts note strong R&D growth and a positive outlook. The company has secured a major research partner that now uses its software as the default clinical platform, and a recent IQVIA deal expands its market reach. Large institutional investors are also increasing exposure to Veeva as part of an AI software play.
Veeva Gains Investor Attention Amid R&D Growth and AI Focus. Veeva Systems is drawing investor interest as analysts note strong R&D growth and a positive outlook. The company has secured a major research partner that now uses its software as the default clinical platform, and a recent IQVIA deal expands its market reach. Large institutional investors are also increasing exposure to Veeva as part of an AI software play.